1Ruigomez A,Johansson S, Wallander M, et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern[ J ]. J Clin Epidemiol ,2002 ,55 (4) : 358 - 363.
2Mabo P. Pavin D,leclercg C. Epidemiology and etiology of atrial fibrillation[J]. Re Prat, 2002, 52(12): 1295 - 1300.
3Kannel WB, Wolf PA, Benjamin EJ,et al. Prevalence, incidence,prognosis and predisposing conditions for atrial fibrillation : Population-based estimates[J]. Am J Cardial, 1998,82, 2N-10N.
4Gallagher MM, Gamm AJ. Classification of atrial fibrillation [ J ].Am J Cardial, 1998, 82: 18N-28N.
5Levy S, Gamin AJ, Saksena S, et al. International consensus on Nomenclature and Classifiication of Atrial Fibrillation : A collaborative project of the working group on arrhythmias and the working group of cardial pacing of the European Society of Cardiology and the North American Society of pacing and electrophysiology[ J ]. J Cardiovas Electrophysiol, 2003,14:443 - 445.
7Morganroth J . Early and late proarrhythmia from antiarrhythmic drug therapy[J]. Cardiovasc Drug ther, 1992 , 6:11 - 16.
8ACC/AHA / ESC guideling for the management of patients with atrial fibrillation[J]. Eur Heart J, 2001, 22:1852 -1932.
9Slavik RS , Tisdale JE , Borzak S. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence prog[ J ].Cardiovas Dis, 2001,44:121 - 152.
10Hart RG, Sherman DG, Easton JD, et al. Prevention of stoke inpatients with nonvavular atrial fibrillation [ J ] . Neuology, 1998,51 : 674 - 679.
